 | 1971 - 748 lapas
...prescription caution statement quoted in section 503 (b) (4) of the Federal Food, Drug, and Cosmetic Act; (ii) The labeling on or within the package from which the...small-bowel lesions consisting of stenosis, with or without mice-ration, associated with the administration of enteric-coated thiazides with potassium salts. These... | |
 | 1972 - 488 lapas
...caution statement quoted In section 503 (b) (4) of the Federal Food. Drug, and Cosmetic Act; and ( 2 ) The labeling on or within the package from which the...requirements of § 1.106(b) of this chapter, Including a recommendation that patients be directed to dlsslove any such tablets in an appropriate amount of... | |
 | 1998 - 196 lapas
...for its use by practitioners in accord with the "full disclosure" labeling requirements of §201.100 of this chapter, including the following warning statement:...small-bowel lesions consisting of stenosis, with or without ulceration, associated with the administration of enteric-coated thiazides with potassium salts. These... | |
 | 1997 - 200 lapas
...for its use by practitioners in accord with the "full disclosure" labeling requirements of §201.100 of this chapter, including the following warning statement:...unpublished, concerning: nonspecific small-bowel lesions consisting1 of stenosis, with or without ulcération, associated with the administration of enteric-coated... | |
 | 2002 - 228 lapas
...the label bears the legend "Caution: Federal law prohibits dispensing without a prescription," and the labeling on or within the package from which the...to be dispensed bears adequate information for its safe and effective use by practitioners, in accord with §201.100(c) of this chapter. (2) The Food... | |
 | 1965 - 1520 lapas
...required by subdivision (vi) of this subparagrapb may be on the crimp of the dispensing tube. (3)(i) Labeling on or within the package from which the drug is to be dispensed bears adequate Information foi its use, including indications, effects dosages, routes, methods, and frequencj and duration of... | |
 | 1993 - 192 lapas
...unless the label tears the legend "Caution: Federal kw prohibits dispensing without a Prescription," and the labeling on or within the package from which the drug is to be dispensed bears adequate ^formation for its safe and effective use by practitioners, in accord with § 201.100(c) of this chapter.... | |
 | 1997 - 200 lapas
...labeling; and (2) The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed. (3) The information required, and in the format specified, by §{201.56 and 201.57. (e) All labeling... | |
 | 2003 - 210 lapas
...labeling; and (2) The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed; Provided, however, That the information required by paragraphs (d) (1) and (2) of this section is not... | |
 | 1994 - 196 lapas
...labeling; and (2) The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed; Provided, however. That the information required by paragraphs (d) (1) and (2) of this section is not... | |
| |
The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed... 
